BioAdaptives Completes Manufacturing Readiness for Upcoming Wellness Product Launch

BioAdaptives, Inc. (OTC: BDPT) announced it has completed commercial manufacturing and logistics supply chain readiness, positioning the company to begin rolling out its next-generation wellness platforms next month. The company reported that it spent the past quarter securing standardized raw materials and partnering with GMP-compliant manufacturing facilities to support anticipated demand for its MyndSystem cognitive performance platform and upcoming Xcellara cellular wellness products.

The dual-platform strategy targets growing global wellness markets. MyndSystem is a stimulant-free, WADA-compliant product designed to support cognitive performance during the day and neurological recovery overnight. The Xcellara platform is intended to support natural stem cell mobilization and is backed by human, double-blind, placebo-controlled clinical data cited by the company. BioAdaptives plans to release additional product specifications, launch timelines and scientific dossiers in the coming weeks.

For more details, the full press release is available at https://ibn.fm/hCUK7. Additional information about BioAdaptives can be found on its website at www.bioadaptives.com.